VOYA Investment Management
PRME icon

VOYA Investment Management’s Prime Medicine PRME Stock Holding History

VOYA Investment Management’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$60.4K Sell
17,345
-146
-0.8% -$556 ﹤0.01% 2261
2025
Q4 		$60.7K Buy
17,491
+4,642
+36% +$20.6K ﹤0.01% 2322
2025
Q3 		$71.2K Sell
12,849
-4,373
-25% -$17.8K ﹤0.01% 2347
2025
Q2 		$42.5K Hold
17,222
– – ﹤0.01% 2622
2025
Q1 		$34.3K Sell
17,222
-951
-5% -$2.43K ﹤0.01% 2585
2024
Q4 		$53.1K Sell
18,173
-1,011
-5% -$3.55K ﹤0.01% 2671
2024
Q3 		$74.2K Hold
19,184
– – ﹤0.01% 2715
2024
Q2 		$98.6K Buy
19,184
+6,278
+49% +$38.1K ﹤0.01% 2673
2024
Q1 		$90.3K Sell
12,906
-3,254
-20% -$24.7K ﹤0.01% 2633
2023
Q4 		$143K Hold
16,160
– – ﹤0.01% 2671
2023
Q3 		$154K Buy
16,160
+417
+3% +$5.42K ﹤0.01% 2623
2023
Q2 		$231K Buy
+15,743
New +$220K ﹤0.01% 2513

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

VOYA Investment Management's PRME Position: Q1 2026 in Review

VOYA Investment Management reduced its Prime Medicine (PRME) stake by 0.83% in Q1 2026, selling an estimated $556 and leaving 17,345 shares worth $60.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2261.

VOYA Investment Management first reported a position in PRME in Q2 2023 and has held it in 12 quarters since. The position peaked at $231K in Q2 2023. 192 funds tracked by Wall St. Rank hold PRME as of Q1 2026.

  • VOYA Investment Management held 17,345 shares of Prime Medicine worth $60.4K as of Q1 2026.
  • VOYA Investment Management sold 146 Prime Medicine shares in Q1 2026, an estimated $556.
  • Prime Medicine made up ﹤0.01% of VOYA Investment Management's portfolio in Q1 2026, its #2261 holding.
  • VOYA Investment Management first reported a position in Prime Medicine in Q2 2023 and has held it in 12 quarters since.
  • VOYA Investment Management's Prime Medicine position peaked at $231K in Q2 2023.
  • 192 funds tracked by Wall St. Rank held Prime Medicine as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.